102 related articles for article (PubMed ID: 26301744)
1. Butanolysis derivatization: improved sensitivity in LC-MS/MS quantitation of heparan sulfate in urine from mucopolysaccharidosis patients.
Trim PJ; Hopwood JJ; Snel MF
Anal Chem; 2015 Sep; 87(18):9243-50. PubMed ID: 26301744
[TBL] [Abstract][Full Text] [Related]
2. LC-MS/MS method for simultaneous quantification of heparan sulfate and dermatan sulfate in urine by butanolysis derivatization.
Forni G; Malvagia S; Funghini S; Scolamiero E; Mura M; Della Bona M; Villanelli F; Damiano R; la Marca G
Clin Chim Acta; 2019 Jan; 488():98-103. PubMed ID: 30395869
[TBL] [Abstract][Full Text] [Related]
3. A straightforward, quantitative ultra-performance liquid chromatography-tandem mass spectrometric method for heparan sulfate, dermatan sulfate and chondroitin sulfate in urine: an improved clinical screening test for the mucopolysaccharidoses.
Zhang H; Wood T; Young SP; Millington DS
Mol Genet Metab; 2015 Feb; 114(2):123-8. PubMed ID: 25458519
[TBL] [Abstract][Full Text] [Related]
4. Validation of disaccharide compositions derived from dermatan sulfate and heparan sulfate in mucopolysaccharidoses and mucolipidoses II and III by tandem mass spectrometry.
Tomatsu S; Montaño AM; Oguma T; Dung VC; Oikawa H; Gutiérrez ML; Yamaguchi S; Suzuki Y; Fukushi M; Barrera LA; Kida K; Kubota M; Orii T
Mol Genet Metab; 2010 Feb; 99(2):124-31. PubMed ID: 19932038
[TBL] [Abstract][Full Text] [Related]
5. Efficient analysis of urinary glycosaminoglycans by LC-MS/MS in mucopolysaccharidoses type I, II and VI.
Auray-Blais C; Bhérer P; Gagnon R; Young SP; Zhang HH; An Y; Clarke JT; Millington DS
Mol Genet Metab; 2011 Jan; 102(1):49-56. PubMed ID: 20934363
[TBL] [Abstract][Full Text] [Related]
6. Synthetic Disaccharide Standards Enable Quantitative Analysis of Stored Heparan Sulfate in MPS IIIA Murine Brain Regions.
He QQ; Trim PJ; Lau AA; King BM; Hopwood JJ; Hemsley KM; Snel MF; Ferro V
ACS Chem Neurosci; 2019 Aug; 10(8):3847-3858. PubMed ID: 31264853
[TBL] [Abstract][Full Text] [Related]
7. A modified liquid chromatography/tandem mass spectrometry method for predominant disaccharide units of urinary glycosaminoglycans in patients with mucopolysaccharidoses.
Chuang CK; Lin HY; Wang TJ; Tsai CC; Liu HL; Lin SP
Orphanet J Rare Dis; 2014 Sep; 9():135. PubMed ID: 25178307
[TBL] [Abstract][Full Text] [Related]
8. A Multiplex Assay for the Diagnosis of Mucopolysaccharidoses and Mucolipidoses.
Langereis EJ; Wagemans T; Kulik W; Lefeber DJ; van Lenthe H; Oussoren E; van der Ploeg AT; Ruijter GJ; Wevers RA; Wijburg FA; van Vlies N
PLoS One; 2015; 10(9):e0138622. PubMed ID: 26406883
[TBL] [Abstract][Full Text] [Related]
9. Development and validation of an LC-MS/MS Method for the quantitation of heparan sulfate in human urine.
Wang K; Li M; Xiao Y; Ma M; Hu W; Liang T; Lin ZJ
Biomed Chromatogr; 2018 Oct; 32(10):e4294. PubMed ID: 29797526
[TBL] [Abstract][Full Text] [Related]
10. Novel heparan sulfate assay by using automated high-throughput mass spectrometry: Application to monitoring and screening for mucopolysaccharidoses.
Shimada T; Kelly J; LaMarr WA; van Vlies N; Yasuda E; Mason RW; Mackenzie W; Kubaski F; Giugliani R; Chinen Y; Yamaguchi S; Suzuki Y; Orii KE; Fukao T; Orii T; Tomatsu S
Mol Genet Metab; 2014; 113(1-2):92-9. PubMed ID: 25092413
[TBL] [Abstract][Full Text] [Related]
11. Glycosaminoglycans analysis in blood and urine of patients with mucopolysaccharidosis.
Khan SA; Mason RW; Giugliani R; Orii K; Fukao T; Suzuki Y; Yamaguchi S; Kobayashi H; Orii T; Tomatsu S
Mol Genet Metab; 2018 Sep; 125(1-2):44-52. PubMed ID: 29779903
[TBL] [Abstract][Full Text] [Related]
12. A novel LC-MS/MS assay for heparan sulfate screening in the cerebrospinal fluid of mucopolysaccharidosis IIIA patients.
Naimy H; Powell KD; Moriarity JR; Wu J; McCauley TG; Haslett PA; Barbier AJ; Qiu Y
Bioanalysis; 2016 Feb; 8(4):285-95. PubMed ID: 26847798
[TBL] [Abstract][Full Text] [Related]
13. Heparan sulfate levels in mucopolysaccharidoses and mucolipidoses.
Tomatsu S; Gutierrez MA; Ishimaru T; Peña OM; Montaño AM; Maeda H; Velez-Castrillon S; Nishioka T; Fachel AA; Cooper A; Thornley M; Wraith E; Barrera LA; Laybauer LS; Giugliani R; Schwartz IV; Frenking GS; Beck M; Kircher SG; Paschke E; Yamaguchi S; Ullrich K; Isogai K; Suzuki Y; Orii T; Noguchi A
J Inherit Metab Dis; 2005; 28(5):743-57. PubMed ID: 16151906
[TBL] [Abstract][Full Text] [Related]
14. Heparan sulfate and dermatan sulfate derived disaccharides are sensitive markers for newborn screening for mucopolysaccharidoses types I, II and III.
de Ruijter J; de Ru MH; Wagemans T; Ijlst L; Lund AM; Orchard PJ; Schaefer GB; Wijburg FA; van Vlies N
Mol Genet Metab; 2012 Dec; 107(4):705-10. PubMed ID: 23084433
[TBL] [Abstract][Full Text] [Related]
15. Quantification of Glycosaminoglycans in Urine by Isotope-Dilution Liquid Chromatography-Electrospray Ionization Tandem Mass Spectrometry.
Zhang H; Young SP; Millington DS
Curr Protoc; 2023 Mar; 3(3):e701. PubMed ID: 36929617
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and mass spectrometric analysis of disaccharides from methanolysis of heparan sulfate.
He QQ; Trim PJ; Snel MF; Hopwood JJ; Ferro V
Org Biomol Chem; 2018 Nov; 16(45):8791-8803. PubMed ID: 30403218
[TBL] [Abstract][Full Text] [Related]
17. Glycosaminoglycan levels in dried blood spots of patients with mucopolysaccharidoses and mucolipidoses.
Kubaski F; Suzuki Y; Orii K; Giugliani R; Church HJ; Mason RW; Dũng VC; Ngoc CT; Yamaguchi S; Kobayashi H; Girisha KM; Fukao T; Orii T; Tomatsu S
Mol Genet Metab; 2017 Mar; 120(3):247-254. PubMed ID: 28065440
[TBL] [Abstract][Full Text] [Related]
18. UPLC-MS/MS detection of disaccharides derived from glycosaminoglycans as biomarkers of mucopolysaccharidoses.
Auray-Blais C; Lavoie P; Tomatsu S; Valayannopoulos V; Mitchell JJ; Raiman J; Beaudoin M; Maranda B; Clarke JT
Anal Chim Acta; 2016 Sep; 936():139-48. PubMed ID: 27566349
[TBL] [Abstract][Full Text] [Related]
19. The relationships between urinary glycosaminoglycan levels and phenotypes of mucopolysaccharidoses.
Lin HY; Lee CL; Lo YT; Wang TJ; Huang SF; Chen TL; Wang YS; Niu DM; Chuang CK; Lin SP
Mol Genet Genomic Med; 2018 Nov; 6(6):982-992. PubMed ID: 30296009
[TBL] [Abstract][Full Text] [Related]
20. Mental retardation in mucopolysaccharidoses correlates with high molecular weight urinary heparan sulphate derived glucosamine.
Coppa GV; Gabrielli O; Zampini L; Maccari F; Mantovani V; Galeazzi T; Santoro L; Padella L; Marchesiello RL; Galeotti F; Volpi N
Metab Brain Dis; 2015 Dec; 30(6):1343-8. PubMed ID: 26016623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
